CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...
T1D Scout founder Yuta Matsuda explains how the swab-based, at-home genetic testing he developed works – and how it can help more families access type 1 diabetes screening. Type 1 diabetes screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results